These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9876203)

  • 21. Relationship between renal function and disposition of oral cefixime.
    Dhib M; Moulin B; Leroy A; Hameau B; Godin M; Johannides R; Fillastre JP
    Eur J Clin Pharmacol; 1991; 41(6):579-83. PubMed ID: 1815970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefiderocol, a Siderophore Cephalosporin for Gram-Negative Bacterial Infections: Pharmacokinetics and Safety in Subjects With Renal Impairment.
    Katsube T; Echols R; Arjona Ferreira JC; Krenz HK; Berg JK; Galloway C
    J Clin Pharmacol; 2017 May; 57(5):584-591. PubMed ID: 27874971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
    Weber W; Harnisch L; Zimmer M; Rokitta C; Mendes P
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):560-4. PubMed ID: 8574507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cefprozil in healthy subjects and patients with renal impairment.
    Shyu WC; Pittman KA; Wilber RB; Matzke GR; Barbhaiya RH
    J Clin Pharmacol; 1991 Apr; 31(4):362-71. PubMed ID: 2037710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
    Buijk SE; Gyssens IC; Mouton JW; Metselaar HJ; Groenland TH; Verbrugh HA; Bruining HA
    J Antimicrob Chemother; 2004 Jul; 54(1):199-205. PubMed ID: 15175266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of renal impairment on the pharmacokinetics of zalcitabine.
    Bazunga M; Tran HT; Kertland H; Chow MS; Massarella J
    J Clin Pharmacol; 1998 Jan; 38(1):28-33. PubMed ID: 9597556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacokinetics of cefodizime in patients undergoing hemodialysis].
    Itagaki N; Hasegawa H; Sakaguchi M; Oono T; Iwamoto I; Horiuchi H; Tsujino M; Takahashi K; Imada A; Horiuchi A
    Jpn J Antibiot; 1991 Dec; 44(12):1392-6. PubMed ID: 1798074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics of cefodizime following intravenous and intramuscular administration of a single dose of 1.0 g.
    Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():59-63. PubMed ID: 2074252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study.
    Stangier J; Rathgen K; Stähle H; Mazur D
    Clin Pharmacokinet; 2010 Apr; 49(4):259-68. PubMed ID: 20214409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics.
    Townsend RW; Akhtar S; Alcorn H; Berg JK; Kowalski DL; Mujais S; Desai AV
    Eur J Clin Pharmacol; 2017 Jun; 73(6):669-678. PubMed ID: 28271239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of sparfloxacin in patients with renal impairment.
    Dorr MB; Johnson RD; Jensen B; Magner D; Marbury T; Talbot GH
    Clin Ther; 1999 Jul; 21(7):1202-15. PubMed ID: 10463518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
    Mamzoridi K; Kasteridou N; Peonides A; Niopas I
    Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
    Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency.
    Müller FO; Terblanchè J; Schall R; van Zyl Smit R; Tucker T; Marais K; Groenewoud G; Porchet HC; Weiner M; Hawarden D
    Br J Clin Pharmacol; 1997 Oct; 44(4):335-41. PubMed ID: 9354307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
    Matzke GR; Abraham PA; Halstenson CE; Keane WF
    Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter study.
    Thalhammer F; Traunmüller F; Böhming HJ; Depisch D; Ilias W; Hollenstein U; Salem G; Wayand W; Burgmann H; Breyer S
    Infection; 1998; 26(2):136-8. PubMed ID: 9561389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients.
    Joynt GM; Lipman J; Gomersall CD; Young RJ; Wong EL; Gin T
    J Antimicrob Chemother; 2001 Apr; 47(4):421-9. PubMed ID: 11266414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.